Compare OPTX & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OPTX | LAB |
|---|---|---|
| Founded | 1981 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 273.5M | 271.0M |
| IPO Year | 2021 | 2008 |
| Metric | OPTX | LAB |
|---|---|---|
| Price | $7.43 | $0.73 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $1.35 |
| AVG Volume (30 Days) | 253.7K | ★ 1.4M |
| Earning Date | 03-31-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 28.57 | ★ 61.54 |
| EPS | N/A | ★ 0.26 |
| Revenue | N/A | ★ $101,937,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.63 |
| P/E Ratio | ★ N/A | $2.86 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.18 | $0.63 |
| 52 Week High | $14.92 | $1.72 |
| Indicator | OPTX | LAB |
|---|---|---|
| Relative Strength Index (RSI) | 49.50 | 51.35 |
| Support Level | $6.17 | $0.70 |
| Resistance Level | $8.90 | $1.02 |
| Average True Range (ATR) | 0.50 | 0.04 |
| MACD | 0.08 | 0.01 |
| Stochastic Oscillator | 54.66 | 57.88 |
Syntec Optics Holdings Inc is vertically integrated from design and component manufacturing for lens system assembly to imaging module integration for system solutions. Making its tools, molding, and nano machining allows close interaction and recut ability, enabling special techniques to hold tolerances to sub-micron levels. It has steadily developed a variety of other complementary manufacturing techniques to provide a wide suite of horizontal capabilities including thin film deposition coatings, glass molding, polymer molding, tool-making, mechanical manufacturing, and nano machining. Syntec Optics focuses on four end markets of defense, medical, consumer, and communications all with several mission-critical applications.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.